News Conference News European Congress on Obesity 2025 Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5 Michael O'Riordan May 12, 2025
News Conference News ESC 2024 Polypills Show Promise in Diverse Hypertensive Patient Groups L.A. McKeown August 31, 2024
News Conference News ESC 2024 Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery Todd Neale August 30, 2024
News Daily News Study Supports Cost-effectiveness of Renal Denervation for Hypertension Todd Neale August 23, 2024
News Daily News FDA Approves Paradise Renal Denervation System: What Comes Next? Todd Neale November 08, 2023
News Conference News TCT 2023 RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months Todd Neale October 31, 2023
News Daily News ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel L.A. McKeown August 22, 2023
News Daily News Frail Patients Also Benefit From Intensive BP Lowering: SPRINT Analysis Todd Neale July 10, 2023
News Daily News Low-Dose Polypills Top Other Approaches for Initial BP Control: Meta-analysis Todd Neale April 26, 2023
News Daily News Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show Caitlin E. Cox April 19, 2023
News Daily News European Societies Define Best Practices for Performing Renal Denervation Todd Neale February 21, 2023
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News AHA 2022 Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering Caitlin E. Cox November 08, 2022